Crossmark

Strategic behavior and entry deterrence by branded drug firms: the case of authorized generic drugs

Crossref DOI link: https://doi.org/10.1007/s10198-024-01721-y

Published Online: 2024-09-24

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yao, Lu https://orcid.org/0000-0003-4781-3378
Liu, Mengde https://orcid.org/0000-0002-1440-3834
License Information

Text and Data Mining valid from 2024-09-24

Version of Record valid from 2024-09-24
More Information

Article History

Received: 28 November 2023

Accepted: 21 August 2024

First Online: 24 September 2024

Declarations

:

: We have no conflicts of interest to disclose.